Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · HCA Healthcare (HCA)

HCA Healthcare: Chief Clinical Officer Michael Cuffe to step down August 31, 2026

Neutral Impact 3 of 5 leadership Written later

HCA Healthcare said Dr. Michael Cuffe, Executive Vice President and Chief Clinical Officer, will step down from that role effective August 31, 2026, under an agreement reached June 15, 2026. He will then serve in a transitional role until February 2027. The filing does not name a successor, and the change involves a senior clinical executive rather than the chief executive or chief financial officer.

Key points

  • Dr. Michael Cuffe steps down as Executive Vice President and Chief Clinical Officer effective August 31, 2026
  • Transitional role with the company continues until February 2027
  • Eligible for benefits under the company's executive severance policy and applicable incentive plans
  • Agreement reached June 15, 2026; 8-K dated June 18, 2026

The filing

CompanyHCA Healthcare (HCA)
Form8-K, current report
Filed with the SECJun 18, 2026, 9:12 AM ET
Accession number0001193125-26-275086

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:21 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 18, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.